Langerhans cells as targets for immunotherapy against skin cancer.
about
Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell ResponsesAutologous therapies in dermatologyUnderstanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapyTargeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacyLangerhans cells and dermal dendritic cells capture protein antigens in the skin: possible targets for vaccination through the skin.Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma modelAdoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in miceLaser microporation of the skin: prospects for painless application of protective and therapeutic vaccines.Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes.Harnessing DNA-induced immune responses for improving cancer vaccines.Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.Immunotherapy in nonmelanoma skin cancer.Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness.The Langerhans cell controversy: are they immunostimulatory or immunoregulatory cells of the skin immune system?CD34+ -derived Langerhans cell-like cells are different from epidermal Langerhans cells in their response to thymic stromal lymphopoietinLangerin, the "Catcher in the Rye": an important receptor for pathogens on Langerhans cells.Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunityEpicutaneous Immunotherapy for Aeroallergen and Food Allergy.Vaccine delivery systems.Skin Diseases Modeling using Combined Tissue Engineering and Microfluidic Technologies.Peritumoral dermis of squamous cell carcinomas in renal transplant recipients contains less CD11c+ myeloid dendritic cells and FoxP3+ T cells compared to immunocompetent controls.
P2860
Q26777948-62EB0AE8-9C2F-4FC8-92DE-F9E5DFC05A9DQ26859003-05948675-EF96-46A9-B266-AEF5B91135CAQ27004702-937762F5-31AC-4918-8F7C-7E6C9CF62E86Q34009407-BDBD9F3E-5F8A-4558-9F9D-C164DE0B4A2CQ34130289-7EFD92AD-A791-46C1-AB70-24B601667124Q34409836-3BE7D311-191C-44AC-89DD-05974622C530Q34428963-FAEB51AC-16DC-4D5C-9943-ACE831936031Q34593082-8D963EFB-F2AD-4249-90AB-22168241B88FQ35138155-1316483F-C45F-4D45-A69A-CA942AED0317Q36694866-E165CBCA-18BF-458F-8332-E3777303FB06Q37868794-205E9140-3F7B-40E9-8F79-EC6F9442ADB6Q37999873-D9AC9F2F-5BEE-41D8-8BC1-B64876669281Q38014084-8DAEC407-8F83-413D-A874-EA6176244555Q39365749-A038DB9A-4613-4C01-AC2C-5B64A76A371AQ39882251-52CEA2E1-43C4-4C07-82E7-B6D16C8A616CQ41858037-2AD950F1-434E-4D1C-B930-FAB355661B73Q41888907-C2151D53-0F0F-46D5-B7C0-1AE52738736DQ42147428-13D8A441-460C-4744-97C8-BEC28E8C5DACQ42578489-8DDA50E6-DEB4-42DF-9E4F-C549500D51BEQ49237143-63552E83-529D-45AB-9FBB-A4932AC72C22Q51189813-47A54AC9-B641-417F-B63E-31EE9C7A5A83Q53556283-C82C3359-510B-4B89-9C60-E5773D1941DC
P2860
Langerhans cells as targets for immunotherapy against skin cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Langerhans cells as targets for immunotherapy against skin cancer.
@ast
Langerhans cells as targets for immunotherapy against skin cancer.
@en
Langerhans cells as targets for immunotherapy against skin cancer.
@nl
type
label
Langerhans cells as targets for immunotherapy against skin cancer.
@ast
Langerhans cells as targets for immunotherapy against skin cancer.
@en
Langerhans cells as targets for immunotherapy against skin cancer.
@nl
prefLabel
Langerhans cells as targets for immunotherapy against skin cancer.
@ast
Langerhans cells as targets for immunotherapy against skin cancer.
@en
Langerhans cells as targets for immunotherapy against skin cancer.
@nl
P2860
P356
P1476
Langerhans cells as targets for immunotherapy against skin cancer
@en
P2093
Florian Sparber
P2860
P304
P356
10.1038/ICB.2010.31
P577
2010-03-30T00:00:00Z